Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$559,144
+$81,754 QoQ
Shares Held
2,222
+1.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#3,060
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 93%
None 7%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bollard Group LLC holds $279,449,341 across 9 Drug Manufacturers - General names. ABBV ranks #6 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
197,160 | $236,479,638 | |
| 2 | MRK |
Merck & Co., Inc.
|
146,931 | $18,880,633 | |
| 3 | JNJ |
Johnson & Johnson
|
60,481 | $15,360,359 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
115,148 | $6,634,827 | |
| 5 | AMGN |
Amgen Inc
|
4,088 | $1,480,346 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
2,222 | $559,144 | |
| 7 | AZN |
Astrazeneca PLC
|
277 | $52,524 | |
| 8 | OGN |
Organon & Co.
|
138 | $1,868 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $559,144 | 2,222 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $477,390 | 2,195 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $497,879 | 2,179 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $504,294 | 2,178 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $404,094 | 2,177 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $434,754 | 2,075 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $368,549 | 2,074 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $446,699 | 2,262 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $387,635 | 2,260 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $659,748 | 3,623 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $599,114 | 3,866 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $683,887 | 4,588 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $614,772 | 4,563 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $703,140 | 4,412 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $709,306 | 4,389 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $585,960 | 4,366 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $665,020 | 4,342 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $700,315 | 4,320 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $581,678 | 4,296 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $460,604 | 4,270 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $478,044 | 4,244 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $456,580 | 4,219 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $449,065 | 4,191 | Shares | Defined | 2021-02-04 | |
| 2020-09-30 | $364,724 | 4,164 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $406,072 | 4,136 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $312,988 | 4,108 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||